Metacare Valuation Multiples

Metacare is valued at $21M as of September 2026, a 3.1x revenue multiple. In the last fiscal year, Metacare revenue was $24M and Metacare EBITDA was $4M.

Metacare Overview

About Metacare

Metacare Co Ltd formerly Smedi Co Ltd has established a hospital in Jeju and exports various types of medical equipments. The company also built its own hospital in China and India and plans to expand its business in Spain and Dubai. The Company and its subsidiaries are divided into pharmaceutical business, medical business, wireless device business, investment and others according to business characteristics by business sector.


Founded

2009

HQ

South Korea

Employees

N/A

Financials (Last FY)

Revenue: $24M
EBITDA: $4M

EV

$75M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Metacare Financials

Metacare reported last fiscal year revenue of $24M and EBITDA of $4M.

In the same fiscal year, Metacare generated $7M in gross profit, $4M in EBITDA, and $364K in net income.


Metacare P&L

In the most recent fiscal year, Metacare reported revenue of $24M and EBITDA of $4M.

Metacare is profitable as of last fiscal year, with gross margin of 30%, EBITDA margin of 16%, and net margin of 2%.

See analyst estimates for Metacare
Last FY202320242025202620272028
Revenue$24M$13M$15M$24M
Gross Profit$7M$5M$6M$7M
Gross Margin30%38%38%30%
EBITDA$4M$2M$3M$4M
EBITDA Margin16%15%21%16%
EBIT Margin4%6%7%4%
Net Profit$364K($11M)$6M$364K
Net Margin2%(84%)42%2%
Net Debt$42M---

Financial data powered by Morningstar, Inc.

Metacare Stock Performance

Metacare has current market cap of $21M, and enterprise value of $75M.

Market Cap Evolution


Metacare's stock price is $0.94.

Metacare share price increased by 1.0% in the last 30 days, and decreased by 59.7% in the last year.

Metacare has an EPS (earnings per share) of $0.02.

See more trading valuation data for Metacare
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$75M$21M0.1%1.0%20.6%-59.7%$0.02

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Metacare Valuation Multiples

Metacare trades at 3.1x EV/Revenue multiple, and 19.3x EV/EBITDA.

See NTM and 2027E valuation multiples for Metacare

Metacare Financial Valuation Multiples

As of September 23, 2026, Metacare has market cap of $21M and EV of $75M.

Metacare has a P/E ratio of 56.7x.

Last FY202320242025202620272028
EV/Revenue3.1x5.9x5.0x3.1x
EV/EBITDA19.3x39.3x23.8x19.3x
EV/EBIT77.9x100.8x67.4x77.9x
EV/Gross Profit10.3x15.5x13.2x10.3x
P/E56.7x(1.9x)3.3x56.7x
EV/FCF(21.0x)(5.7x)64.3x(21.0x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Metacare Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Metacare Margins & Growth Rates

In the most recent fiscal year, Metacare reported gross margin of 30%, EBITDA margin of 16%, and net margin of 2%.

See estimated margins and future growth rates for Metacare

Metacare Margins

Last FY20242025202720282029
Gross Margin30%38%30%
EBITDA Margin16%21%16%
EBIT Margin4%7%4%
Net Margin2%42%2%
FCF Margin(15%)8%(15%)

Metacare Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth17%60%
Gross Profit Growth18%28%
EBITDA Growth65%23%
EBIT Growth50%(14%)
Net Profit Growth(158%)(94%)
FCF Growth(109%)(406%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Metacare Operational KPIs

Access forward-looking KPIs for Metacare
Last FY202320242025202620272028
S&M Expenses to Revenue5%8%6%5%
G&A Expenses to Revenue1%0%1%1%
R&D Expenses to Revenue-7%--
Opex to Revenue26%32%31%26%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
CareView Communications$9M$84K4.4x-474.7x-
TempraMed Technologies$2M($18M)11.9x-(1.2x)-
Cambridge Cognition$13M($891K)1.5x1.4x(21.8x)(12.2x)
Fill Up Media$19M$2M1.7x1.3x20.6x6.1x
Resonance Health$8M($688K)2.7x-(31.0x)-
Verify Smart-($775K)--(24.6x)-
ACCESS Newswire$23M$1M0.8x0.8x17.4x6.7x
Firefly Neuroscience$1M($20M)8.4x-(0.5x)-

This data is available for Pro users. Sign up to see all Metacare competitors and their valuation data.

Start Free Trial

Investments by Metacare

Metacare has invested in 1 company to date.

Latest investment by Metacare was on November 26th 2021. Metacare invested in Liting labs in their $6M Series A round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Metacare

Liting labs
Description
Liting Labs is a Taiwan-based cosmeceutical company headquartered in Taipei that develops and distributes skincare products infused with biotech ingredients like exosomes and stem cell extracts. Its lineup includes anti-aging serums, acne treatments, and whitening creams sold through clinics and e-commerce. Established in 2018, Liting Labs exports to Asia-Pacific markets and collaborates with dermatologists for clinical validations.
HQ CountrySouth Korea
HQ City
Seoul
Deal Date26 Nov 2021
RoundSeries A
Raised$6M
InvestorsMetacare
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Metacare investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Metacare

When was Metacare founded?Metacare was founded in 2009.
Where is Metacare headquartered?Metacare is headquartered in South Korea.
Is Metacare publicly listed?Yes, Metacare is a public company listed on Korea Exchange.
What is the stock symbol of Metacare?Metacare trades under 118000 ticker.
When did Metacare go public?Metacare went public in 2009.
Who are competitors of Metacare?Metacare main competitors include CareView Communications, TempraMed Technologies, Cambridge Cognition, Fill Up Media, Resonance Health, Verify Smart, ACCESS Newswire, Firefly Neuroscience, Impact Fusion International, MRSO.
What is the current market cap of Metacare?Metacare's current market cap is $21M.
What is the current revenue of Metacare?Metacare's last fiscal year revenue is $24M.
What is the current EV/Revenue multiple of Metacare?Current revenue multiple of Metacare is 3.1x.
Is Metacare profitable?No, Metacare is not profitable.
How many companies Metacare has acquired to date?Metacare hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Metacare has invested to date?As of September 2026, Metacare has invested in 1 company.
What was the last Metacare investment?On 26th November 2021 Metacare invested in Liting labs, participating in a $6M Series A round.
In what companies Metacare invested in?Metacare invested in Liting labs.

See public comps similar to Metacare

Lists including Metacare

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial